Sino Biological/EGF / Epidermal Growth Factor Neutralizing Antibody/1/10605-R001
商品编号:
10605-R001
品牌:
sinobiological
市场价:
¥0.00
美元价:
0.00
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
EGF / Epidermal Growth Factor Neutralizing Antibody General Information
Product name
EGF / Epidermal Growth Factor Neutralizing Antibody
Validated applications
Neutralization
Species reactivity
Reacts with: Human
Specificity
Human EGFHas cross-reactivity in ELISA withCanine EGF (Catalog # 170013-D07E)Mouse EGF (Catalog # 50482-MNCH)
Immunogen
Recombinant Human EGF / Epidermal Growth Factor Protein (Catalog#10605-HNAE)
Preparation
This antibody was obtained from a rabbit immunized with purified, recombinant Human EGF / Epidermal Growth Factor (rh EGF / Epidermal Growth Factor; Catalog#10605-HNAE; NP_001954.2; Asn971-Arg1023) and was produced using recombinant antibody technology.
Source
Monoclonal Rabbit IgG Clone #R001
Purification
Protein A
Formulation
0.2 μm filtered solution in Histidine and Arginine buffer containing 120mM NaCl, 0.02% Tween 80, pH6.0
Conjugate
Unconjugated
Endotoxin
< 3="">
Form
Liquid
Shipping
This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Storage
This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.
EGF / Epidermal Growth Factor Neutralizing Antibody Validated Applications
Notes
Block: | In a functional ELISA, 1.2 µg/mL of this antibody will block >80% of the binding of 5 µg/mL of biotinylated Human EGF (Catalog# 10605-H01H-B) to immobilized Recombinant Human EGFR (Catalog# 10001-H08B) coated at 10 µg/mL (100 µL/well) in the plate. |
Neutralization: | The neutralization activity of EGF Neutralizing Antibody is Measured by its ability to neutralize EGF induced proliferation in the Balb/c 3T3 mouse embryonic fibroblast cell line. The Neutralization titer (IC50) is typically 2.5-7.5 μg/mL in the presence of 2 ng/mL Recombinant Human EGF. |
Please Note: Optimal concentrations/dilutions should be determined by the end user.
EGF / Epidermal Growth Factor Neutralizing Antibody Images

Cell Proliferation Induced by EGF was Neutralized by Human EGF Antibody. Recombinant Human EGF stimulates proliferation in the Balb/c 3T3 mouse embryonic fibroblast cell line. Proliferation elicited by Recombinant Human EGF (2 ng/mL) is neutralized by increasing concentrations of Human EGF Monoclonal Antibody (Catalog # 10605-R001). The IC50 is typically 2.5-7.5 μg/mL.
EGF / Epidermal Growth Factor Neutralizing Antibody: Synonyms
Anti-Epidermal Growth Factor Antibody; Anti-HOMG4 Antibody; Anti-URG Antibody
EGF Background Information
EGF is the founding member of the EGF-family of proteins. Members of this protein family have highly similar structural and functional characteristics. EGF contains 9 EGF-like domains and 9 LDL-receptor class B repeats. Human EGF is a 6045-Da protein with 53 amino acid residues and three intramolecular disulfide bonds. As a low-molecular-weight polypeptide, EGF was first purified from the mouse submandibular gland, but since then it was found in many human tissues including submandibular gland, parotid gland. It can also be found in human platelets, macrophages, urine, saliva, milk, and plasma. EGF is a growth factor that stimulates the growth of various epidermal and epithelial tissues in vivo and in vitro and of some fibroblasts in cell culture. It results in cellular proliferation, differentiation, and survival. Salivary EGF, which seems also regulated by dietary inorganic iodine, also plays an important physiological role in the maintenance of oro-esophageal and gastric tissue integrity. EGF acts by binding with high affinity to epidermal growth factor receptor on the cell surface and stimulating the intrinsic protein-tyrosine kinase activity of the receptor. The tyrosine kinase activity, in turn, initiates a signal transduction cascade that results in a variety of biochemical changes within the cell - a rise in intracellular calcium levels, increased glycolysis and protein synthesis, and increases in the expression of certain genes including the gene for EGFR - that ultimately lead to DNA synthesis and cell proliferation.
Full Name
epidermal growth factor
References
- Chen JX, et al. (2011) Involvement of c-Src/STAT3 signal in EGF-induced proliferation of rat spermatogonial stem cells. Mol Cell Biochem. 358(1-2):67-73.
- Guo Y, et al. (2012) Correlations among ERCC1, XPB, UBE2I, EGF, TAL2 and ILF3 revealed by gene signatures of histological subtypes of patients with epithelial ovarian cancer. Oncol Rep. 27(1):286-92.
- Kim S, et al. (2012) Smad7 acts as a negative regulator of the epidermal growth factor (EGF) signaling pathway in breast cancer cells. Cancer Lett. 314(2):147-54.
- Chatterton RT Jr, et al. (2010) Breast ductal lavage for assessment of breast cancer biomarkers. Horm Cancer. 1(4):197-204.
- Modulation of hepatitis B virus infection by epidermal growth factor secreted from liver sinusoidal endothelial cellsAuthorChen, SW;Himeno, M;Koui, Y;Sugiyama, M;Nishitsuji, H;Mizokami, M;Shimotohno, K;Miyajima, A;Kido, T;Year2020JournalSci RepApplicationbindingPubMed ID: 32873852FoldedExpand
If you couldn"t find the specific citation, you can:
- Find All Citations
- Submit a CitationGet a Publication Reward
- Leave Us a Message
Recombinant Antibody Production Service
High-throughput Recombinant Antibody Production
Large-scale Antibody Production
Antibody Development Service
Rabbit MAb Production Service
Mouse MAb Production Service
Rabbit PAb Production Service
Phospho-Specific Antibody
Anti-Idiotype Antibody
Fast Antibody Development Service
Mouse MAb
Rabbit PAb
More Antibody Production Service
Hybridoma Antibody Production
Chimeric Antibody
Antibody Fragment
Bispecific Antibody
We also have Immunoassay Service. Click to see more.
品牌介绍
北京义翘神州科技股份有限公司(Sino Biological Inc.)是一家从事生物试剂研发、生产、销售并提供技术服务的生物科技公司,主要业务包括重组蛋白、抗体、基因和培养基等产品,以及重组蛋白、抗体的开发和生物分析检测等服务。义翘神州为全球的药品研发企业和生命科学研究机构提供高质量的生物试剂产品和高水平的技术服务。公司目前生产和销售的现货产品种类超过 4.6 万种,其中重组蛋白约 6,000 种,包括超过 3,800 种人源细胞表达重组蛋白产品,能够全面满足客户对于最接近人体天然蛋白结构和性质的重组蛋白需求;公司还能提供约 12,000 种抗体,其中单克隆抗体数量约 4,600 种,能够覆盖生命科学研究的多个领域,为分子生物学、细胞生物学、免疫学、发育生物学、干细胞研究等基础科研方向和创新药物研发提供「一站式」生物试剂产品和技术服务。义翘神州的客户涵盖大学、科研院所、医药研发企业等国内外各类生物研发单位。目前公司已经在美国、欧洲建立了子公司,已成为生物试剂行业国内领先的科技公司之一。
联络我们